Lexicon Pharmaceuticals Inc

Healthcare · Biotechnology

1.90$ +5.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Lexicon Pharmaceuticals Inc (LXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 185 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LXRX
Line item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	471	655	476	437	284	418	204	137	194	229	298	185
Current Assets	369	532	358	322	173	338	158	89	141	177	246	102
Cash	339	521	347	311	160	36	126	64	46	22	67	34
Cash & Short-Term Investments	339	521	347	311	160	272	152	87	138	170	238	96
Receivables	1.0	0.9	7.5	4.8	5.9	57	0.4	0.0	0.0	1.0	3.5	2.4
Inventory	4.8	0.0	0.0	1.9	4.7	4.2	0.0	–	0.0	0.4	0.2	0.3
Property, Plant & Equipment	1.1	21	19	18	16	14	0.3	1.2	2.1	–	–	–
Goodwill	45	45	45	45	45	45	45	45	45	45	45	45
Intangible Assets	53	53	53	52	50	20	–	–	–	–	–	–
Total Liabilities	187	369	318	384	311	301	47	23	77	136	152	77
Current Liabilities	45	123	165	124	37	65	47	22	23	32	45	21
Short-Term Debt	10	-23	-16	2.1	-14	12	12	1.1	1.3	1.3	1.2	6.2
Accounts Payable	13	20	53	39	12	12	5.5	9.2	10	14	15	3.1
Long-Term Debt	88	104	85	232	244	234	–	–	49	100	100	49
Shareholders' Equity	284	286	157	52	-1,472	117	156	114	117	93	146	108
Retained Earnings	-1,104	-1,109	-1,250	-1,381	-1,472	-1,341	-1,400	-1,488	-1,590	-1,767	-1,967	-2,018
Shares Outstanding	76	104	104	105	106	117	111	146	166	221	320	363

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings